Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltdverified

603707.SS

Price:

$9.21

Market Cap:

$14.88B

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd manufactures and sells heparin sodium and low molecular weight heparin products for pharmaceutical companies in the People's Republic of China. It offers enoxaparin sodium, dalteparin sodium, and naqu heparin calcium injections. The company also exports its products primarily to the European and American countries. The company was founded in 2000 and is based in Nanjing, the People's Republic of China.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-07-19

Stock Exchange

SHH

Ticker

603707.SS

The Enterprise Value as of December 2025 (TTM) for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) is 15.85B

According to Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 15.85B. This represents a change of -23.80% compared to the average of 20.80B of the last 4 quarters.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) Historical Enterprise Value (quarterly & annually)

How has 603707.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd over the last ten years is 22.24B. The current 15.85B Enterprise Value has changed 7.03% with respect to the historical average. Over the past ten years (40 quarters), 603707.SS's Enterprise Value was at its highest in in the December 2021 quarter at 51.24B. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

22.24B

Median

23.54B

Minimum

2.59B

Maximum

52.53B

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 289.59%

Maximum Annual Enterprise Value = 52.53B

Minimum Annual Increase = -41.55%

Minimum Annual Enterprise Value = 2.59B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202422.54B-8.17%
202324.54B-20.07%
202230.70B-41.55%
202152.53B47.83%
202035.53B15.65%
201930.73B289.59%
20187.89B-33.03%
201711.78B227.53%
20163.60B39.05%
20152.59B-3.60%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) Average Enterprise Value

How has 603707.SS Enterprise Value performed in the past?

The current Enterprise Value of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

25.93B

5-year avg

33.17B

10-year avg

22.24B

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) Enterprise Value vs. Peers

How is 603707.SS’s Enterprise Value compared to its peers?

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd’s Enterprise Value is greater than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (15.79B), less than Zhejiang Jingxin Pharmaceutical Co., Ltd. (16.12B), greater than Pacific Shuanglin Bio-pharmacy Co., Ltd. (13.29B), less than Apeloa Pharmaceutical Co.,Ltd (18.22B), greater than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (13.41B), less than Shanghai Haoyuan Chemexpress Co., Ltd. (16.21B), greater than Changzhou Qianhong Biopharma CO.,LTD (9.37B), greater than Tibet Rhodiola Pharmaceutical Holding Co. (12.26B), greater than Micro-Tech (Nanjing) Co., Ltd. (13.48B), greater than Zhejiang Hisun Pharmaceutical Co., Ltd. (13.89B),

Build a custom stock screener for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's Enterprise Value?

What is the highest Enterprise Value for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)?

What is the 3-year average Enterprise Value for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)?

What is the 5-year average Enterprise Value for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)?

How does the current Enterprise Value for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) compare to its historical average?